FDA probes compounding pharmacies over quality concerns

(By: Paige Twenter for Becker’s Hospital Review)

The FDA plans to gather information from 250 compounding outsourcing pharmacies amid safety and quality concerns.

In a May 1 notice, the agency said it will survey outsourcing facilities about challenges and opportunities related to market and business viability, compliance, quality production and interactions with the FDA. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.